\-\ Texto\\:\\ \ \(0\)\
\-\ generalized\\ erythematous\\ firm\\ papules\\ sparing\\ the\\ face\\ and\\ scalp\\.\ \(0\)\
\-\ palms\\ and\\ soles\\:\\ reddish\\-brown\\ flat\\ round\\ papules\\ with\\ collarette\\ of\\ scale\\.\\ no\\ lymphadenopathy\\.\\ left\\ eye\\:\\ conjunctival\\ injected\\.\ \(0\)\
\-\ laboratory\\:\\ rpr\\-reactive\\,\\ vrdl\\-\\ reactive\\,\\ hiv\\-negative\\,\\ cerebral\\ spinal\\ fluid\\ vrdl\\:\\ reactive\ \(0\)\
\-\ treatment\\:\\ intravenous\\ aqueous\\ crystalline\\ pencillin\\ g\\;\\ 3\\ million\\ iu\\ every\\ four\\ hours\ \(0\)\
\-\ histopathology\\:\\ the\\ biopsy\\ shows\\ a\\ granulomatous\\ dermatitis\\ with\\ scattered\\ plasma\\ cells\\.\ \(0\)\
\-\ secondary\\ syphilis\\ and\\ neurosyphilis\ \(0\)\
\-\ \\â\\€\\¢\\ ricketsia\ \(0\)\
\-\ \\â\\€\\¢\\ treponema\ \(0\)\
\-\ 48\\ year\\ old\\ woman\\ with\\ a\\ three\\ week\\ history\\ of\\ an\\ eruption\\ of\\ erythematous\\,\\ asymptomatic\\ papules\\ over\\ her\\ trunk\\ and\\ extremities\\.\\ she\\ noted\\ an\\ extension\\ of\\ lesions\\ onto\\ her\\ palms\\ and\\ soles\\ over\\ the\\ last\\ week\\.\\ she\\ also\\ complained\\ of\\ new\\ onset\\ headaches\\ and\\ left\\ eye\\ inflammation\\ over\\ the\\ past\\ month\\ that\\ was\\ previously\\ attributed\\ to\\ an\\ allergic\\ conjunctivitis\\.\\ she\\ denied\\ genital\\ lesions\\.\ \(0\)\
\-\ case\\ 20\\ \\(27th\\ annual\\ uniformed\\ services\\ dermatology\\ seminar\\,\\ 2003\\)\\ secondary\\ syphilis\\ and\\ neurosyphilis\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ papules\\:\\ 0\\.26951485724851276\ \(0\)\
\-\ soles\\:\\ 0\\.2514027303561291\ \(0\)\
\-\ vrdl\\:\\ 0\\.2514027303561291\ \(0\)\
\-\ palms\\:\\ 0\\.2402287302754317\ \(0\)\
\-\ neurosyphilis\\:\\ 0\\.23230065104861483\ \(0\)\
\-\ reactive\\:\\ 0\\.2023764568314764\ \(0\)\
\-\ syphilis\\:\\ 0\\.18409537042658808\ \(0\)\
\-\ erythematous\\:\\ 0\\.15957225537561584\ \(0\)\
\-\ she\\:\\ 0\\.14036930906049513\ \(0\)\
\-\ over\\:\\ 0\\.13111814372297684\ \(0\)\
\-\ eye\\:\\ 0\\.12576016324345984\ \(0\)\
\-\ collarette\\:\\ 0\\.12570136517806454\ \(0\)\
\-\ aqueous\\:\\ 0\\.12570136517806454\ \(0\)\
\-\ pencillin\\:\\ 0\\.12570136517806454\ \(0\)\
\-\ ricketsia\\:\\ 0\\.12570136517806454\ \(0\)\
\-\ treponema\\:\\ 0\\.12011436513771585\ \(0\)\
\-\ and\\:\\ 0\\.11369467523593672\ \(0\)\
\-\ million\\:\\ 0\\.11056332548395874\ \(0\)\
\-\ crystalline\\:\\ 0\\.10843924664907927\ \(0\)\
\-\ conjunctivitis\\:\\ 0\\.10659928587055031\ \(0\)\
\-\ week\\:\\ 0\\.1057358352598991\ \(0\)\
\-\ conjunctival\\:\\ 0\\.10221123626275568\ \(0\)\
\-\ eruption\\:\\ 0\\.10221123626275568\ \(0\)\
\-\ genital\\:\\ 0\\.10101228583020162\ \(0\)\
\-\ iu\\:\\ 0\\.09888820699532215\ \(0\)\
\-\ her\\:\\ 0\\.09821187224923106\ \(0\)\
\-\ dermatitis\\:\\ 0\\.0946802807046361\ \(0\)\
\-\ secondary\\:\\ 0\\.09317851972551719\ \(0\)\
\-\ 27th\\:\\ 0\\.09266019660899856\ \(0\)\
\-\ plasma\\:\\ 0\\.09146124617644451\ \(0\)\
\-\ lesions\\:\\ 0\\.0902837930224142\ \(0\)\
\-\ an\\:\\ 0\\.09017117571765343\ \(0\)\
\-\ allergic\\:\\ 0\\.08983828574950425\ \(0\)\
\-\ attributed\\:\\ 0\\.08793467941881943\ \(0\)\
\-\ trunk\\:\\ 0\\.08749720656303608\ \(0\)\
\-\ injected\\:\\ 0\\.08587424613609583\ \(0\)\
\-\ onto\\:\\ 0\\.08375016730121634\ \(0\)\
\-\ sparing\\:\\ 0\\.08249664555953692\ \(0\)\
\-\ flat\\:\\ 0\\.08134771056318073\ \(0\)\
\-\ scalp\\:\\ 0\\.07978612768780792\ \(0\)\
\-\ histopathology\\:\\ 0\\.07930259605640265\ \(0\)\
\-\ seminar\\:\\ 0\\.07906704779846804\ \(0\)\
\-\ scale\\:\\ 0\\.07838363976506231\ \(0\)\
\-\ uniformed\\:\\ 0\\.07838363976506231\ \(0\)\
\-\ services\\:\\ 0\\.07711080584426672\ \(0\)\
\-\ of\\:\\ 0\\.07691010665675939\ \(0\)\
\-\ dermatology\\:\\ 0\\.07690964551918823\ \(0\)\
\-\ every\\:\\ 0\\.07613314502015897\ \(0\)\
\-\ complained\\:\\ 0\\.07576071052283204\ \(0\)\
\-\ generalized\\:\\ 0\\.07504474493739147\ \(0\)\
\-\ annual\\:\\ 0\\.07264926679537423\ \(0\)\
\-\ intravenous\\:\\ 0\\.07165956293695831\ \(0\)\
\-\ firm\\:\\ 0\\.07125623938624694\ \(0\)\
\-\ denied\\:\\ 0\\.07099376978296495\ \(0\)\
\-\ face\\:\\ 0\\.07086438632020983\ \(0\)\
\-\ 2003\\:\\ 0\\.07073620644199002\ \(0\)\
\-\ granulomatous\\:\\ 0\\.06987085790585212\ \(0\)\
\-\ scattered\\:\\ 0\\.06839512725552187\ \(0\)\
\-\ 48\\:\\ 0\\.06807590284249009\ \(0\)\
\-\ round\\:\\ 0\\.0644042013164245\ \(0\)\
\-\ last\\:\\ 0\\.06392900810436224\ \(0\)\
\-\ four\\:\\ 0\\.06369741882865392\ \(0\)\
\-\ lymphadenopathy\\:\\ 0\\.06354516051101879\ \(0\)\
\-\ inflammation\\:\\ 0\\.06317171658271496\ \(0\)\
\-\ previously\\:\\ 0\\.06309822714161713\ \(0\)\
\-\ the\\:\\ 0\\.06273561652170215\ \(0\)\
\-\ cells\\:\\ 0\\.06056156546231704\ \(0\)\
\-\ hours\\:\\ 0\\.05990670524328566\ \(0\)\
\-\ extremities\\:\\ 0\\.0597333792152455\ \(0\)\
\-\ headaches\\:\\ 0\\.05863045173256216\ \(0\)\
\-\ laboratory\\:\\ 0\\.057078335870645786\ \(0\)\
\-\ spinal\\:\\ 0\\.055812467141093794\ \(0\)\
\-\ extension\\:\\ 0\\.05564076102459541\ \(0\)\
\-\ biopsy\\:\\ 0\\.05509704833994501\ \(0\)\
\-\ cerebral\\:\\ 0\\.0544560379939701\ \(0\)\
\-\ new\\:\\ 0\\.05437796845060512\ \(0\)\
\-\ left\\:\\ 0\\.0536255660408255\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.05351058922585641\ \(0\)\
\-\ three\\:\\ 0\\.05276366060639428\ \(0\)\
\-\ past\\:\\ 0\\.05116380033162667\ \(0\)\
\-\ 20\\:\\ 0\\.05070899873215037\ \(0\)\
\-\ onset\\:\\ 0\\.050472439487932334\ \(0\)\
\-\ month\\:\\ 0\\.047814374049331296\ \(0\)\
\-\ with\\:\\ 0\\.04617363625629608\ \(0\)\
\-\ shows\\:\\ 0\\.046132447723037415\ \(0\)\
\-\ fluid\\:\\ 0\\.04538293888306769\ \(0\)\
\-\ noted\\:\\ 0\\.041674551084301965\ \(0\)\
\-\ woman\\:\\ 0\\.040936066400268596\ \(0\)\
\-\ case\\:\\ 0\\.03948868184299009\ \(0\)\
\-\ treatment\\:\\ 0\\.03744220073249067\ \(0\)\
\-\ also\\:\\ 0\\.036972026786860165\ \(0\)\
\-\ that\\:\\ 0\\.03411022681200446\ \(0\)\
\-\ history\\:\\ 0\\.03003043201828737\ \(0\)\
\-\ was\\:\\ 0\\.027393500115123596\ \(0\)\
\-\ no\\:\\ 0\\.02556040595234636\ \(0\)\
\-\ year\\:\\ 0\\.02422352246608503\ \(0\)\
\-\ old\\:\\ 0\\.02326296674783472\ \(0\)\
\-\ to\\:\\ 0\\.01965029174376191\ \(0\)\
